APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Skin Patch

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transdermal Skin Patch Industry Growth and Trends Forecast to 2032

26 December 2025101 pages

Choose your research edition.

Industry ResearchTransdermal Skin Patch Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Skin Patch Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Transdermal Skin Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Skin Patch Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Skin Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Transdermal Skin Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Skin Patch include Actavis, Changzhou Siyao, Henan Lingrui Pharmaceutical, Hisamitsu Pharmaceutical, Luye Pharma Group Ltd., Mundipharma, Purdue Pharma L.P., Rfl Pharmaceutical and Teikoku Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transdermal Skin Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transdermal Skin Patch market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transdermal Skin Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transdermal Skin Patch.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Transdermal Skin Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transdermal Skin Patch Market by Company

Actavis

Changzhou Siyao

Henan Lingrui Pharmaceutical

Hisamitsu Pharmaceutical

Luye Pharma Group Ltd.

Mundipharma

Purdue Pharma L.P.

Rfl Pharmaceutical

Teikoku Pharma

Mylan

Novartis

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

Transdermal Skin Patch Segment by Type

Buprenorphine Transdermal Skin Patch

Fentanyl Transdermal Skin Patch

Clonidine Transdermal Skin Patch

Nicotine Transdermal Skin Patch

Transdermal Skin Patch Segment by Application

Relieve Severe Pain

Stop Smoking Cigarettes

Treat an Overactive Bladder

Others

Transdermal Skin Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Skin Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Transdermal Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Buprenorphine Transdermal Skin Patch Table 2. Major Company of Fentanyl Transdermal Skin Patch Table 3. Major Company of Clonidine Transdermal Skin Patch Table 4. Major Company of Nicotine Transdermal Skin Patch Table 5. Global Transdermal Skin Patch Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 7. Global Transdermal Skin Patch Sales Market Share in Volume by Type (2021-2026) Table 8. Global Transdermal Skin Patch Sales by Type (2021-2026) & (US$ Million) Table 9. Global Transdermal Skin Patch Sales Market Share in Value by Type (2021-2026) Table 10. Global Transdermal Skin Patch Price by Type (2021-2026) & (US$/Unit) Table 11. Global Transdermal Skin Patch Sales by Type (2027-2032) & (W Units) Table 12. Global Transdermal Skin Patch Sales Market Share in Volume by Type (2027-2032) Table 13. Global Transdermal Skin Patch Sales by Type (2027-2032) & (US$ Million) Table 14. Global Transdermal Skin Patch Sales Market Share in Value by Type (2027-2032) Table 15. Global Transdermal Skin Patch Price by Type (2027-2032) & (US$/Unit) Table 16. North America Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 17. North America Transdermal Skin Patch Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 19. Europe Transdermal Skin Patch Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Transdermal Skin Patch Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 23. Latin America Transdermal Skin Patch Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Transdermal Skin Patch Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Transdermal Skin Patch Sales by Type (2021-2026) & (US$ Million) Table 26. Transdermal Skin Patch Industry Trends Table 27. Transdermal Skin Patch Industry Drivers Table 28. Transdermal Skin Patch Industry Opportunities and Challenges Table 29. Transdermal Skin Patch Industry Restraints Table 30. Global Transdermal Skin Patch Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Transdermal Skin Patch Revenue Market Share by Company (2021-2026) Table 32. Global Transdermal Skin Patch Sales by Company (2021-2026) & (W Units) Table 33. Global Transdermal Skin Patch Sales Share by Company (2021-2026) Table 34. Global Transdermal Skin Patch Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Transdermal Skin Patch Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Transdermal Skin Patch Major Company Production Sites and Headquarters Table 37. Global Transdermal Skin Patch Company, Product Type & Application Table 38. Global Transdermal Skin Patch Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Transdermal Skin Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Transdermal Skin Patch Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Transdermal Skin Patch Sales by Region (2021-2026) & (W Units) Table 43. Global Transdermal Skin Patch Sales Market Share in Volume by Region (2021-2026) Table 44. Global Transdermal Skin Patch Sales by Region (2021-2026) & (US$ Million) Table 45. Global Transdermal Skin Patch Sales Market Share in Value by Region (2021-2026) Table 46. Global Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Transdermal Skin Patch Sales by Region (2027-2032) & (W Units) Table 48. Global Transdermal Skin Patch Sales Market Share in Volume by Region (2027-2032) Table 49. Global Transdermal Skin Patch Sales by Region (2027-2032) & (US$ Million) Table 50. Global Transdermal Skin Patch Sales Market Share in Value by Region (2027-2032) Table 51. Global Transdermal Skin Patch Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Transdermal Skin Patch Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 54. Global Transdermal Skin Patch Sales Market Share in Volume by Application (2021-2026) Table 55. Global Transdermal Skin Patch Sales by Application (2021-2026) & (US$ Million) Table 56. Global Transdermal Skin Patch Sales Market Share in Value by Application (2021-2026) Table 57. Global Transdermal Skin Patch Price by Application (2021-2026) & (US$/Unit) Table 58. Global Transdermal Skin Patch Sales by Application (2027-2032) & (W Units) Table 59. Global Transdermal Skin Patch Sales Market Share in Volume by Application (2027-2032) Table 60. Global Transdermal Skin Patch Sales by Application (2027-2032) & (US$ Million) Table 61. Global Transdermal Skin Patch Sales Market Share in Value by Application (2027-2032) Table 62. Global Transdermal Skin Patch Price by Application (2027-2032) & (US$/Unit) Table 63. North America Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 64. North America Transdermal Skin Patch Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 66. Europe Transdermal Skin Patch Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Transdermal Skin Patch Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 70. Latin America Transdermal Skin Patch Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Transdermal Skin Patch Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Transdermal Skin Patch Sales by Application (2021-2026) & (US$ Million) Table 73. Actavis Company Information Table 74. Actavis Business Overview Table 75. Actavis Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Actavis Transdermal Skin Patch Product Portfolio Table 77. Actavis Recent Development Table 78. Changzhou Siyao Company Information Table 79. Changzhou Siyao Business Overview Table 80. Changzhou Siyao Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Changzhou Siyao Transdermal Skin Patch Product Portfolio Table 82. Changzhou Siyao Recent Development Table 83. Henan Lingrui Pharmaceutical Company Information Table 84. Henan Lingrui Pharmaceutical Business Overview Table 85. Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio Table 87. Henan Lingrui Pharmaceutical Recent Development Table 88. Hisamitsu Pharmaceutical Company Information Table 89. Hisamitsu Pharmaceutical Business Overview Table 90. Hisamitsu Pharmaceutical Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio Table 92. Hisamitsu Pharmaceutical Recent Development Table 93. Luye Pharma Group Ltd. Company Information Table 94. Luye Pharma Group Ltd. Business Overview Table 95. Luye Pharma Group Ltd. Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio Table 97. Luye Pharma Group Ltd. Recent Development Table 98. Mundipharma Company Information Table 99. Mundipharma Business Overview Table 100. Mundipharma Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Mundipharma Transdermal Skin Patch Product Portfolio Table 102. Mundipharma Recent Development Table 103. Purdue Pharma L.P. Company Information Table 104. Purdue Pharma L.P. Business Overview Table 105. Purdue Pharma L.P. Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio Table 107. Purdue Pharma L.P. Recent Development Table 108. Rfl Pharmaceutical Company Information Table 109. Rfl Pharmaceutical Business Overview Table 110. Rfl Pharmaceutical Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio Table 112. Rfl Pharmaceutical Recent Development Table 113. Teikoku Pharma Company Information Table 114. Teikoku Pharma Business Overview Table 115. Teikoku Pharma Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Teikoku Pharma Transdermal Skin Patch Product Portfolio Table 117. Teikoku Pharma Recent Development Table 118. Mylan Company Information Table 119. Mylan Business Overview Table 120. Mylan Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Mylan Transdermal Skin Patch Product Portfolio Table 122. Mylan Recent Development Table 123. Novartis Company Information Table 124. Novartis Business Overview Table 125. Novartis Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Novartis Transdermal Skin Patch Product Portfolio Table 127. Novartis Recent Development Table 128. Johnson & Johnson Company Information Table 129. Johnson & Johnson Business Overview Table 130. Johnson & Johnson Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Johnson & Johnson Transdermal Skin Patch Product Portfolio Table 132. Johnson & Johnson Recent Development Table 133. Teva Pharmaceutical Industries Ltd. Company Information Table 134. Teva Pharmaceutical Industries Ltd. Business Overview Table 135. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio Table 137. Teva Pharmaceutical Industries Ltd. Recent Development Table 138. North America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. North America Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 140. North America Transdermal Skin Patch Sales Market Share by Country (2021-2026) Table 141. North America Transdermal Skin Patch Sales Forecast by Country (2027-2032) & (W Units) Table 142. North America Transdermal Skin Patch Sales Market Share Forecast by Country (2027-2032) Table 143. North America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Transdermal Skin Patch Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Transdermal Skin Patch Market Share by Country (2021-2026) Table 146. North America Transdermal Skin Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Transdermal Skin Patch Market Share Forecast by Country (2027-2032) Table 148. Europe Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 149. Europe Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 150. Europe Transdermal Skin Patch Sales Market Share by Country (2021-2026) Table 151. Europe Transdermal Skin Patch Sales Forecast by Country (2027-2032) & (W Units) Table 152. Europe Transdermal Skin Patch Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Transdermal Skin Patch Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Transdermal Skin Patch Market Share by Country (2021-2026) Table 156. Europe Transdermal Skin Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Transdermal Skin Patch Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 160. Asia-Pacific Transdermal Skin Patch Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Transdermal Skin Patch Sales Forecast by Country (2027-2032) & (W Units) Table 162. Asia-Pacific Transdermal Skin Patch Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Transdermal Skin Patch Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Transdermal Skin Patch Market Share by Country (2021-2026) Table 166. Asia-Pacific Transdermal Skin Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Transdermal Skin Patch Market Share Forecast by Country (2027-2032) Table 168. Latin America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 169. Latin America Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 170. Latin America Transdermal Skin Patch Sales Market Share by Country (2021-2026) Table 171. Latin America Transdermal Skin Patch Sales Forecast by Country (2027-2032) & (W Units) Table 172. Latin America Transdermal Skin Patch Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Transdermal Skin Patch Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Transdermal Skin Patch Market Share by Country (2021-2026) Table 176. Latin America Transdermal Skin Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Transdermal Skin Patch Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Transdermal Skin Patch Sales by Country (2021-2026) & (W Units) Table 180. Middle East and Africa Transdermal Skin Patch Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Transdermal Skin Patch Sales Forecast by Country (2027-2032) & (W Units) Table 182. Middle East and Africa Transdermal Skin Patch Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Transdermal Skin Patch Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Transdermal Skin Patch Market Share by Country (2021-2026) Table 186. Middle East and Africa Transdermal Skin Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Transdermal Skin Patch Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Transdermal Skin Patch Distributors List Table 191. Transdermal Skin Patch Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Transdermal Skin Patch Image Figure 2. Global Transdermal Skin Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Skin Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Skin Patch Sales (2021-2032) & (W Units) Figure 5. Buprenorphine Transdermal Skin Patch Image Figure 6. Global Buprenorphine Transdermal Skin Patch Sales YoY Growth (2021-2032) & (W Units) Figure 7. Fentanyl Transdermal Skin Patch Image Figure 8. Global Fentanyl Transdermal Skin Patch Sales YoY Growth (2021-2032) & (W Units) Figure 9. Clonidine Transdermal Skin Patch Image Figure 10. Global Clonidine Transdermal Skin Patch Sales YoY Growth (2021-2032) & (W Units) Figure 11. Nicotine Transdermal Skin Patch Image Figure 12. Global Nicotine Transdermal Skin Patch Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Transdermal Skin Patch Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Transdermal Skin Patch Market Share by Type 2025 VS 2032 Figure 15. North America Transdermal Skin Patch Sales Market Share in Volume by Type in 2025 Figure 16. North America Transdermal Skin Patch Sales Market Share in Value by Type in 2025 Figure 17. Europe Transdermal Skin Patch Sales Market Share in Volume by Type in 2025 Figure 18. Europe Transdermal Skin Patch Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Transdermal Skin Patch Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Transdermal Skin Patch Sales Market Share in Value by Type in 2025 Figure 21. Latin America Transdermal Skin Patch Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Transdermal Skin Patch Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Transdermal Skin Patch Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Transdermal Skin Patch Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Transdermal Skin Patch Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Relieve Severe Pain Image Figure 28. Global Relieve Severe Pain Sales YoY Growth (2021-2032) & (W Units) Figure 29. Stop Smoking Cigarettes Image Figure 30. Global Stop Smoking Cigarettes Sales YoY Growth (2021-2032) & (W Units) Figure 31. Treat an Overactive Bladder Image Figure 32. Global Treat an Overactive Bladder Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Transdermal Skin Patch Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Transdermal Skin Patch Market Share by Application 2025 VS 2032 Figure 37. North America Transdermal Skin Patch Sales Market Share in Volume by Application in 2025 Figure 38. North America Transdermal Skin Patch Sales Market Share in Value by Application in 2025 Figure 39. Europe Transdermal Skin Patch Sales Market Share in Volume by Application in 2025 Figure 40. Europe Transdermal Skin Patch Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Transdermal Skin Patch Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Transdermal Skin Patch Sales Market Share in Value by Application in 2025 Figure 43. Latin America Transdermal Skin Patch Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Transdermal Skin Patch Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Transdermal Skin Patch Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Transdermal Skin Patch Sales Market Share in Value by Application in 2025 Figure 47. North America Transdermal Skin Patch Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Transdermal Skin Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Transdermal Skin Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Transdermal Skin Patch Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Transdermal Skin Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Transdermal Skin Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Transdermal Skin Patch Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Transdermal Skin Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Transdermal Skin Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Transdermal Skin Patch Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Transdermal Skin Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Transdermal Skin Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Transdermal Skin Patch Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Transdermal Skin Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Transdermal Skin Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Transdermal Skin Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Transdermal Skin Patch Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Transdermal Skin Patch Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Buprenorphine Transdermal Skin Patch
  • Fentanyl Transdermal Skin Patch
  • Clonidine Transdermal Skin Patch
  • Nicotine Transdermal Skin Patch
Applications
  • Relieve Severe Pain
  • Stop Smoking Cigarettes
  • Treat an Overactive Bladder
  • Others
Companies covered
  • Actavis
  • Changzhou Siyao
  • Henan Lingrui Pharmaceutical
  • Hisamitsu Pharmaceutical
  • Luye Pharma Group Ltd.
  • Mundipharma
  • Purdue Pharma L.P.
  • Rfl Pharmaceutical
  • Teikoku Pharma
  • Mylan
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Skin Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Transdermal Skin Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Transdermal Skin Patch Market by Type
  6. 1.3.1 Buprenorphine Transdermal Skin Patch
  7. 1.3.2 Fentanyl Transdermal Skin Patch
  8. 1.3.3 Clonidine Transdermal Skin Patch
  9. 1.3.4 Nicotine Transdermal Skin Patch
  10. 1.4 Global Transdermal Skin Patch Market Size by Type
  11. 1.4.1 Global Transdermal Skin Patch Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Transdermal Skin Patch Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Transdermal Skin Patch Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Transdermal Skin Patch Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Transdermal Skin Patch Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Transdermal Skin Patch Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Transdermal Skin Patch Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Transdermal Skin Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Transdermal Skin Patch Industry Trends
  2. 2.2 Transdermal Skin Patch Industry Drivers
  3. 2.3 Transdermal Skin Patch Industry Opportunities and Challenges
  4. 2.4 Transdermal Skin Patch Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Transdermal Skin Patch Revenue (2021-2026)
  2. 3.2 Global Top Players by Transdermal Skin Patch Sales (2021-2026)
  3. 3.3 Global Top Players by Transdermal Skin Patch Price (2021-2026)
  4. 3.4 Global Transdermal Skin Patch Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Skin Patch Major Company Production Sites & Headquarters
  6. 3.6 Global Transdermal Skin Patch Company, Product Type & Application
  7. 3.7 Global Transdermal Skin Patch Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Skin Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Skin Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Skin Patch Tier 1, Tier 2, and Tier 3
4 Transdermal Skin Patch Regional Status and Outlook
  1. 4.1 Global Transdermal Skin Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Transdermal Skin Patch Historic Market Size by Region
  3. 4.2.1 Global Transdermal Skin Patch Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Transdermal Skin Patch Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Transdermal Skin Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Transdermal Skin Patch Forecasted Market Size by Region
  7. 4.3.1 Global Transdermal Skin Patch Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Transdermal Skin Patch Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Transdermal Skin Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transdermal Skin Patch by Application
  1. 5.1 Transdermal Skin Patch Market by Application
  2. 5.1.1 Relieve Severe Pain
  3. 5.1.2 Stop Smoking Cigarettes
  4. 5.1.3 Treat an Overactive Bladder
  5. 5.1.4 Others
  6. 5.2 Global Transdermal Skin Patch Market Size by Application
  7. 5.2.1 Global Transdermal Skin Patch Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Transdermal Skin Patch Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Transdermal Skin Patch Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Transdermal Skin Patch Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Transdermal Skin Patch Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Transdermal Skin Patch Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Transdermal Skin Patch Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Transdermal Skin Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actavis
  2. 6.1.1 Actavis Company Information
  3. 6.1.2 Actavis Business Overview
  4. 6.1.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actavis Transdermal Skin Patch Product Portfolio
  6. 6.1.5 Actavis Recent Developments
  7. 6.2 Changzhou Siyao
  8. 6.2.1 Changzhou Siyao Company Information
  9. 6.2.2 Changzhou Siyao Business Overview
  10. 6.2.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio
  12. 6.2.5 Changzhou Siyao Recent Developments
  13. 6.3 Henan Lingrui Pharmaceutical
  14. 6.3.1 Henan Lingrui Pharmaceutical Company Information
  15. 6.3.2 Henan Lingrui Pharmaceutical Business Overview
  16. 6.3.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio
  18. 6.3.5 Henan Lingrui Pharmaceutical Recent Developments
  19. 6.4 Hisamitsu Pharmaceutical
  20. 6.4.1 Hisamitsu Pharmaceutical Company Information
  21. 6.4.2 Hisamitsu Pharmaceutical Business Overview
  22. 6.4.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio
  24. 6.4.5 Hisamitsu Pharmaceutical Recent Developments
  25. 6.5 Luye Pharma Group Ltd.
  26. 6.5.1 Luye Pharma Group Ltd. Company Information
  27. 6.5.2 Luye Pharma Group Ltd. Business Overview
  28. 6.5.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolio
  30. 6.5.5 Luye Pharma Group Ltd. Recent Developments
  31. 6.6 Mundipharma
  32. 6.6.1 Mundipharma Company Information
  33. 6.6.2 Mundipharma Business Overview
  34. 6.6.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mundipharma Transdermal Skin Patch Product Portfolio
  36. 6.6.5 Mundipharma Recent Developments
  37. 6.7 Purdue Pharma L.P.
  38. 6.7.1 Purdue Pharma L.P. Company Information
  39. 6.7.2 Purdue Pharma L.P. Business Overview
  40. 6.7.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolio
  42. 6.7.5 Purdue Pharma L.P. Recent Developments
  43. 6.8 Rfl Pharmaceutical
  44. 6.8.1 Rfl Pharmaceutical Company Information
  45. 6.8.2 Rfl Pharmaceutical Business Overview
  46. 6.8.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio
  48. 6.8.5 Rfl Pharmaceutical Recent Developments
  49. 6.9 Teikoku Pharma
  50. 6.9.1 Teikoku Pharma Company Information
  51. 6.9.2 Teikoku Pharma Business Overview
  52. 6.9.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio
  54. 6.9.5 Teikoku Pharma Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Transdermal Skin Patch Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Novartis
  62. 6.11.1 Novartis Company Information
  63. 6.11.2 Novartis Business Overview
  64. 6.11.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novartis Transdermal Skin Patch Product Portfolio
  66. 6.11.5 Novartis Recent Developments
  67. 6.12 Johnson & Johnson
  68. 6.12.1 Johnson & Johnson Company Information
  69. 6.12.2 Johnson & Johnson Business Overview
  70. 6.12.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio
  72. 6.12.5 Johnson & Johnson Recent Developments
  73. 6.13 Teva Pharmaceutical Industries Ltd.
  74. 6.13.1 Teva Pharmaceutical Industries Ltd. Company Information
  75. 6.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
  76. 6.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolio
  78. 6.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Transdermal Skin Patch Sales by Country
  2. 7.1.1 North America Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Transdermal Skin Patch Sales by Country (2021-2026)
  4. 7.1.3 North America Transdermal Skin Patch Sales Forecast by Country (2027-2032)
  5. 7.2 North America Transdermal Skin Patch Market Size by Country
  6. 7.2.1 North America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Transdermal Skin Patch Market Size by Country (2021-2026)
  8. 7.2.3 North America Transdermal Skin Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Transdermal Skin Patch Sales by Country
  2. 8.1.1 Europe Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Transdermal Skin Patch Sales by Country (2021-2026)
  4. 8.1.3 Europe Transdermal Skin Patch Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Transdermal Skin Patch Market Size by Country
  6. 8.2.1 Europe Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Transdermal Skin Patch Market Size by Country (2021-2026)
  8. 8.2.3 Europe Transdermal Skin Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Transdermal Skin Patch Sales by Country
  2. 9.1.1 Asia-Pacific Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Transdermal Skin Patch Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Transdermal Skin Patch Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Transdermal Skin Patch Market Size by Country
  6. 9.2.1 Asia-Pacific Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Transdermal Skin Patch Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Transdermal Skin Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Transdermal Skin Patch Sales by Country
  2. 10.1.1 South America Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Transdermal Skin Patch Sales by Country (2021-2026)
  4. 10.1.3 South America Transdermal Skin Patch Sales Forecast by Country (2027-2032)
  5. 10.2 South America Transdermal Skin Patch Market Size by Country
  6. 10.2.1 South America Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Transdermal Skin Patch Market Size by Country (2021-2026)
  8. 10.2.3 South America Transdermal Skin Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Transdermal Skin Patch Sales by Country
  2. 11.1.1 Middle East and Africa Transdermal Skin Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Transdermal Skin Patch Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Transdermal Skin Patch Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Transdermal Skin Patch Market Size by Country
  6. 11.2.1 Middle East and Africa Transdermal Skin Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Transdermal Skin Patch Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Transdermal Skin Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Transdermal Skin Patch Value Chain Analysis
  2. 12.1.1 Transdermal Skin Patch Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Transdermal Skin Patch Production Mode & Process
  7. 12.2 Transdermal Skin Patch Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Transdermal Skin Patch Distributors
  10. 12.2.3 Transdermal Skin Patch Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst